Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Baroja

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Rheumatology International|January 1, 1988
Down-regulation of immunoglobulin and IgM-rheumatoid factor synthesis by oral treatment of rheumatoid arthritis patients with a nonsteroidal antiinflammatory drugM A Rodríguez, M L Baroja, M Leon-Ponte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Specific CD3 epsilon association of a phosphodiesterase 4B isoform determines its selective tyrosine phosphorylation after CD3 ligationM L Baroja, L B Cieslinski, T J Torphy, et al.
Cytokine|January 1, 1990
Accessory cell-derived helper signals in human T-cell activation with phytohemagglutinin: induction of interleukin 2-responsiveness by interleukin 6, and production of interleukin 2 by interleukin 1 [corrected]R Kuhweide, J Van Damme, K Lorre, et al.
Viral Immunology|January 1, 1994
CD3- and CD28-activating pathways in HCV infectionJ A Corado, F I Toro, M L Baroja, et al.
Viral Immunology|January 1, 1996
T cell hyperreactivity to IL-6 in chronic nonviremic HBV carriers despite normal IL-6 receptor or gp130 expressionM L Baroja, F L Sirit, H Rivera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 1999
The inhibitory function of CTLA-4 does not require its tyrosine phosphorylationM L Baroja, D Luxenberg, T Chau, et al.
Arthritis and Rheumatism|April 1, 1991
Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosusI L Stekman, A M Blasini, M Leon-Ponte, et al.
Journal of Clinical Immunology|September 1, 1987
Helper activity by human large granular lymphocytes in in vitro immunoglobulin synthesisM A Rodriguez, I Blanca, M L Baroja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expressionB M Carreno, F Bennett, T A Chau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2009
Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft toleranceW Ge, J Jiang, M L Baroja, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Rheumatology International|January 1, 1988
Down-regulation of immunoglobulin and IgM-rheumatoid factor synthesis by oral treatment of rheumatoid arthritis patients with a nonsteroidal antiinflammatory drugM A Rodríguez, M L Baroja, M Leon-Ponte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Specific CD3 epsilon association of a phosphodiesterase 4B isoform determines its selective tyrosine phosphorylation after CD3 ligationM L Baroja, L B Cieslinski, T J Torphy, et al.
Cytokine|January 1, 1990
Accessory cell-derived helper signals in human T-cell activation with phytohemagglutinin: induction of interleukin 2-responsiveness by interleukin 6, and production of interleukin 2 by interleukin 1 [corrected]R Kuhweide, J Van Damme, K Lorre, et al.
Viral Immunology|January 1, 1994
CD3- and CD28-activating pathways in HCV infectionJ A Corado, F I Toro, M L Baroja, et al.
Viral Immunology|January 1, 1996
T cell hyperreactivity to IL-6 in chronic nonviremic HBV carriers despite normal IL-6 receptor or gp130 expressionM L Baroja, F L Sirit, H Rivera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 1999
The inhibitory function of CTLA-4 does not require its tyrosine phosphorylationM L Baroja, D Luxenberg, T Chau, et al.
Arthritis and Rheumatism|April 1, 1991
Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosusI L Stekman, A M Blasini, M Leon-Ponte, et al.
Journal of Clinical Immunology|September 1, 1987
Helper activity by human large granular lymphocytes in in vitro immunoglobulin synthesisM A Rodriguez, I Blanca, M L Baroja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expressionB M Carreno, F Bennett, T A Chau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2009
Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft toleranceW Ge, J Jiang, M L Baroja, et al.
Pageof 3